Skip to main content
# Title Research Member Research Year
11 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
12 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
13 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
14 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
15 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Shimaa Hassan Shabaan Hassan 2023
17 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2021
18 Laparoscopic versus Open Complete Mesocolic Excision for Right Colon Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2021
19 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Dr. Hanaan Ahmed Mohammed Ahmed 2021
20 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Marwa Tammam Ameen Hammam 2021